Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissection

2018 ◽  
Vol 129 (2) ◽  
pp. 387-395 ◽  
Author(s):  
You-Ping Liu ◽  
Hao Li ◽  
Rui You ◽  
Ji-Bin Li ◽  
Xue-Kui Liu ◽  
...  
2019 ◽  
Vol 133 ◽  
pp. S630-S631
Author(s):  
R. Sim ◽  
S. Mueller ◽  
G. Iyer ◽  
N.C. Tan ◽  
K.C. Soo ◽  
...  

2020 ◽  
Author(s):  
xiyin Guan ◽  
Xing Xing ◽  
Xiaoshen Wang ◽  
Xiayun He ◽  
Hongmei Ying ◽  
...  

Abstract Objective: To evaluate clinical outcomes of cervical node recurrence/residual tumor of nasopharyngeal carcinoma (NPC) with treatment decisions made by a multidisciplinary treatment (MDT) team. Methods: Between March 2010 and July 2019, patients who had previously undergone definitive intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma and presented with residual or recurrent cervical lymph nodes were enrolled in our study. Clinical features and treatment modalities were retrospectively reviewed, and survival outcomes were analyzed. Results: A total of 183 patients were enrolled in the study, among whom 139 underwent neck dissection, and the remaining 44 were either considered not eligible for surgery or refused surgery. For the two groups of patients, the 3-year overall survival (OS) was 73.4% vs 36.8% (p=0.000), and the progression-free survival (PFS) was 57.1% vs 32.3% (p=0.004), respectively. Patients who underwent neck dissection had a significantly better clinical outcome and shorter latency between the prior treatment and detection of neck recurrence/residual tumor than those who did not. Conclusion: For regional failure cases that have no contradictions for surgery and are predicted to benefit from surgery by the MDT team, neck dissection could be the best choice. It is important for an experienced MDT team to choose the optimum treatment modalities for patients for the cervical failure of NPC. Regular follow-up after prior treatment contributes to the early detection of regional failure and provides a chance for surgery.


2015 ◽  
Vol 43 (8) ◽  
pp. 1571-1576 ◽  
Author(s):  
J.Y. Chen ◽  
L. Zhang ◽  
Q.H. Ji ◽  
D.S. Li ◽  
Q. Shen ◽  
...  

2014 ◽  
Vol 41 (5) ◽  
pp. 485-490 ◽  
Author(s):  
Hanwei Peng ◽  
Steven J. Wang ◽  
Xihong Yang ◽  
Jianying Lin ◽  
Haipeng Guo ◽  
...  

2006 ◽  
Vol 24 (18_suppl) ◽  
pp. 10082-10082
Author(s):  
Y. Huang ◽  
B. Zee ◽  
M. Lam ◽  
P. Teo

10082 Background: The commonly employed Kaplan-Meier (KM) method is based on the assumption that different failure types (local-regional, distant, etc.) are independent. In reality, these failures occur at different stages in disease progression and are strongly correlated with each other. The assumption of independence of different failure types may violate certain assumptions in the modeling, and hence may affect the clinical interpretation and treatment selection. A better approach to estimate cause-specific failure probability is to calculate cumulative incidence rates by taking into account other events within a competing risk framework, in which the dependency of different failures are considered. Methods: The data was based on a large retrospective cohort study conducted at the Prince of Wales Hospital in Hong Kong, China, in 1996–97. 945 patients with nasopharyngeal carcinoma (NPC) had been treated with a standard protocol and been followed up regularly with a median follow-up period of 69 months (1–122 months). We calculated the cumulative incidence rates of local-regional failure and distant metastasis, and compared the result against KM method. In competing risk analysis, local regional failure, distant metastases and death were considered as competing events during the remaining lifetime of NPC patients from first presentation. Results: The probability of local-regional failure and distant metastasis was higher by KM method than by competing risk method. The result indicated that KM analysis overestimated event rate and the difference became larger in a longer follow-up period, when more competing events occurred. Conclusion: Kaplan-Meier analysis overestimates the probability of cause-specific failure. Competing risk analysis provides us a more accurate method in the determination of the pattern of failure. It provides better evidence to clinicians to enable them to predict the prognosis and select proper therapy. [Table: see text] No significant financial relationships to disclose.


Sign in / Sign up

Export Citation Format

Share Document